Zobrazeno 1 - 10
of 80
pro vyhledávání: '"HAN Jindi"'
Autor:
MA Xu, HAN Sen, NIE Jun, DAI Ling, HU Weiheng, CHEN Xiaoling, ZHANG Jie, MA Xiangjuan, TIAN Guangming, WU Di, LONG Jieran, HAN Jindi, WANG Yang, ZHANG Ziran, ZHANG Yanhua, WANG Dan, FANG Jian
Publikováno v:
Zhongliu Fangzhi Yanjiu, Vol 47, Iss 5, Pp 335-339 (2020)
Objective To explore the impact of venous thromboembolism (VTE) on the diagnosis and treatment of lung cancer patients. Methods We retrospectively analyzed the clinical data of lung cancer patients with VTE treated in Peking University Cancer Hospita
Externí odkaz:
https://doaj.org/article/ef0fa47068ad439e940d6a732a695cf1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tian, Guangming, Zhao, Xinliang, Nie, Jun, Dai, Ling, Hu, Weiheng, Zhang, Jie, Chen, Xiaoling, Han, Jindi, Ma, Xiangjuan, Wu, Di, Han, Sen, Long, Jieran, Wang, Yang, Zhang, Ziran, Fang, Jian
Publikováno v:
J Thorac Dis
BACKGROUND: Anaplastic lymphoma kinase (ALK) gene rearrangement is a series of mutations of non-small cell lung cancer (NSCLC) patients. Since 2011, multiple ALK inhibitors (ALKis) have been developed and launched for targeted therapy. In this study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb709e5422b4f24def848539e56d8aa5
https://doi.org/10.21037/jtd-22-622
https://doi.org/10.21037/jtd-22-622
Autor:
Wu Di, Cong Yue, Zhang Ziran, Zhang Jie, Nie Jun, Dai Ling, Hu Weiheng, Chen Xiaoling, Ma Xiangjuan, Tian Guangming, Han Jindi, Han Sen, Wang Yang, Long Jieran, Fang Jian
Publikováno v:
Future Oncology. 18:669-677
Aim: To investigate the efficacy, safety and optimal dosage of bevacizumab in non-squamous, non-small-cell lung cancer (NSCLC) patients with malignant pleural effusion (MPE). Methods: 20 patients were enrolled and received intrapleural injection of b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ca584051393e769d2aa9b697c0f5852
https://doi.org/10.2217/fon-2021-1035
https://doi.org/10.2217/fon-2021-1035
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zhang, Jie, Wu, Di, Zhang, Ziran, Long, Jieran, Tian, Guangming, Wang, Yang, Ma, Xiangjuan, Chen, Xiaoling, Han, Jindi, Hu, Weiheng, Dai, Ling, Nie, Jun, Fang, Jian
Supplemental material, sj-docx-4-tct-10.1177_15330338211039676 for Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study by Jie Zhang, Di Wu, Ziran Zhang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b9cb6a32a2a6668d28d624c91647a32
Autor:
Zhang, Jie, Wu, Di, Zhang, Ziran, Long, Jieran, Tian, Guangming, Wang, Yang, Ma, Xiangjuan, Chen, Xiaoling, Han, Jindi, Hu, Weiheng, Dai, Ling, Nie, Jun, Fang, Jian
Supplemental material, sj-docx-1-tct-10.1177_15330338211039676 for Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study by Jie Zhang, Di Wu, Ziran Zhang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::533e698872ef1aa5ee4bb78aecb2209d
Autor:
Zhang, Jie, Wu, Di, Zhang, Ziran, Long, Jieran, Tian, Guangming, Wang, Yang, Ma, Xiangjuan, Chen, Xiaoling, Han, Jindi, Hu, Weiheng, Dai, Ling, Nie, Jun, Fang, Jian
Supplemental material, sj-docx-2-tct-10.1177_15330338211039676 for Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study by Jie Zhang, Di Wu, Ziran Zhang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::275e4591be06d84cb23a734fe3da1410
Autor:
Zhang, Jie, Wu, Di, Zhang, Ziran, Long, Jieran, Tian, Guangming, Wang, Yang, Ma, Xiangjuan, Chen, Xiaoling, Han, Jindi, Hu, Weiheng, Dai, Ling, Nie, Jun, Fang, Jian
Supplemental material, sj-pdf-3-tct-10.1177_15330338211039676 for Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study by Jie Zhang, Di Wu, Ziran Zhang,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65dd0d9d7858b691a7324babedc3c62f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.